The use of G‐CSF in our study was more liberal than in usual practice, as our policy at PMH at the time was to try to maintain a lenalidomide dose of 25 mg throughout relapse using growth factor support rather than to reduce the dose if neutropenia occurred 18, 19. Here, CSF3 is linked to Decreased total neutrophil count.